Short Interest in Bionano Genomics, Inc. (NASDAQ:BNGO) Increases By 30.0%

Bionano Genomics, Inc. (NASDAQ:BNGO) saw a large increase in short interest in January. As of January 31st, there was short interest totalling 443,900 shares, an increase of 30.0% from the January 15th total of 341,500 shares. Based on an average trading volume of 188,600 shares, the days-to-cover ratio is currently 2.4 days. Currently, 19.1% of the company’s stock are short sold.

Institutional Investors Weigh In On Bionano Genomics

Several large investors have recently made changes to their positions in BNGO. Carret Asset Management LLC grew its stake in shares of Bionano Genomics by 39.9% in the 4th quarter. Carret Asset Management LLC now owns 119,000 shares of the company’s stock valued at $34,000 after buying an additional 33,945 shares in the last quarter. XTX Topco Ltd bought a new stake in shares of Bionano Genomics in the 4th quarter valued at approximately $45,000. GSA Capital Partners LLP bought a new stake in shares of Bionano Genomics in the 3rd quarter valued at approximately $46,000. Renaissance Technologies LLC bought a new stake in shares of Bionano Genomics in the 4th quarter valued at approximately $46,000. Finally, Jane Street Group LLC bought a new stake in shares of Bionano Genomics in the 4th quarter valued at approximately $118,000. Institutional investors own 11.35% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, LADENBURG THALM/SH SH cut Bionano Genomics from a “buy” rating to a “neutral” rating in a research note on Friday, November 15th.

Bionano Genomics Stock Performance

NASDAQ:BNGO traded up $0.23 on Friday, hitting $5.76. 364,504 shares of the company’s stock traded hands, compared to its average volume of 286,334. The company has a current ratio of 1.43, a quick ratio of 0.99 and a debt-to-equity ratio of 0.07. Bionano Genomics has a 1 year low of $4.75 and a 1 year high of $81.00. The firm has a 50-day moving average price of $10.99 and a 200-day moving average price of $18.73.

Bionano Genomics Company Profile

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.